# Immune Profile in Subjects With New Onset Type 1 Diabetes

> **NCT02801942** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **PROCEDURE:** Inguinal lymph node fine needle aspirate biopsy
- **PROCEDURE:** Inguinal lymph node core biopsy
- **PROCEDURE:** Peripheral blood collection
- **OTHER:** Pre- and post-biopsy questionnaire

## Key facts

- **NCT ID:** NCT02801942
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-25
- **Primary completion:** 2017-12-21
- **Final completion:** 2017-12-21
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801942, "Immune Profile in Subjects With New Onset Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02801942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*